Ambivalent aspects of interleukin-6 in cerebral ischemia: Inflammatory versus neurotrophic aspects

Shigeaki Suzuki, Kortaro Tanaka, Norihiro Suzuki

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

Interleukin-6 (IL-6) is pleiotropic cytokine involved in many central nervous system disorders including stroke, and elevated serum IL-6 has been found in acute stroke patients. IL-6 is implicated in the inflammation, which contributes to both injury and repair process after cerebral ischemia. However, IL-6 is one of the neurotrophic cytokines sharing a common receptor subunit, gp130, with other neurotrophic cytokines, such as leukemia inhibitory factor (LIF) and ciliary neurotrophic factor. The expression of IL-6 is most prominently identified in neurons in the peri-ischemic regions, and LIF expression shows a similar pattern. The direct injection of these cytokines into the brain after ischemia can reduce ischemic brain injury. The cytokine receptors are localized on the neuron surface, suggesting that neurons are the cytokine target. The major IL-6 downstream signaling pathway is JAK-STAT, and Stat3 activation occurs mainly in neurons during postischemic reperfusion. Further investigation is necessary to clarify the exact role of Stat3 signaling in neuroprotection. Taken together, the information suggests that IL-6 plays a double role in cerebral ischemia, as an inflammatory mediator during the acute phase and as a neurotrophic mediator between the subacute and prolonged phases.

Original languageEnglish
Pages (from-to)464-479
Number of pages16
JournalJournal of Cerebral Blood Flow and Metabolism
Volume29
Issue number3
DOIs
Publication statusPublished - 2009

Fingerprint

Brain Ischemia
Interleukin-6
Cytokines
Leukemia Inhibitory Factor
Neurons
Stroke
Ciliary Neurotrophic Factor
Cytokine Receptors
Central Nervous System Diseases
Brain Injuries
Reperfusion
Inflammation
Injections
Wounds and Injuries
Serum

Keywords

  • Cerebral ischemia
  • Interleukin-6
  • JAK-STAT
  • Leukemia inhibitory factor
  • Neuron
  • Stat3

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Neurology

Cite this

Ambivalent aspects of interleukin-6 in cerebral ischemia : Inflammatory versus neurotrophic aspects. / Suzuki, Shigeaki; Tanaka, Kortaro; Suzuki, Norihiro.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 29, No. 3, 2009, p. 464-479.

Research output: Contribution to journalArticle

@article{570f941049944967a9d85a3ca6b0c504,
title = "Ambivalent aspects of interleukin-6 in cerebral ischemia: Inflammatory versus neurotrophic aspects",
abstract = "Interleukin-6 (IL-6) is pleiotropic cytokine involved in many central nervous system disorders including stroke, and elevated serum IL-6 has been found in acute stroke patients. IL-6 is implicated in the inflammation, which contributes to both injury and repair process after cerebral ischemia. However, IL-6 is one of the neurotrophic cytokines sharing a common receptor subunit, gp130, with other neurotrophic cytokines, such as leukemia inhibitory factor (LIF) and ciliary neurotrophic factor. The expression of IL-6 is most prominently identified in neurons in the peri-ischemic regions, and LIF expression shows a similar pattern. The direct injection of these cytokines into the brain after ischemia can reduce ischemic brain injury. The cytokine receptors are localized on the neuron surface, suggesting that neurons are the cytokine target. The major IL-6 downstream signaling pathway is JAK-STAT, and Stat3 activation occurs mainly in neurons during postischemic reperfusion. Further investigation is necessary to clarify the exact role of Stat3 signaling in neuroprotection. Taken together, the information suggests that IL-6 plays a double role in cerebral ischemia, as an inflammatory mediator during the acute phase and as a neurotrophic mediator between the subacute and prolonged phases.",
keywords = "Cerebral ischemia, Interleukin-6, JAK-STAT, Leukemia inhibitory factor, Neuron, Stat3",
author = "Shigeaki Suzuki and Kortaro Tanaka and Norihiro Suzuki",
year = "2009",
doi = "10.1038/jcbfm.2008.141",
language = "English",
volume = "29",
pages = "464--479",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Ambivalent aspects of interleukin-6 in cerebral ischemia

T2 - Inflammatory versus neurotrophic aspects

AU - Suzuki, Shigeaki

AU - Tanaka, Kortaro

AU - Suzuki, Norihiro

PY - 2009

Y1 - 2009

N2 - Interleukin-6 (IL-6) is pleiotropic cytokine involved in many central nervous system disorders including stroke, and elevated serum IL-6 has been found in acute stroke patients. IL-6 is implicated in the inflammation, which contributes to both injury and repair process after cerebral ischemia. However, IL-6 is one of the neurotrophic cytokines sharing a common receptor subunit, gp130, with other neurotrophic cytokines, such as leukemia inhibitory factor (LIF) and ciliary neurotrophic factor. The expression of IL-6 is most prominently identified in neurons in the peri-ischemic regions, and LIF expression shows a similar pattern. The direct injection of these cytokines into the brain after ischemia can reduce ischemic brain injury. The cytokine receptors are localized on the neuron surface, suggesting that neurons are the cytokine target. The major IL-6 downstream signaling pathway is JAK-STAT, and Stat3 activation occurs mainly in neurons during postischemic reperfusion. Further investigation is necessary to clarify the exact role of Stat3 signaling in neuroprotection. Taken together, the information suggests that IL-6 plays a double role in cerebral ischemia, as an inflammatory mediator during the acute phase and as a neurotrophic mediator between the subacute and prolonged phases.

AB - Interleukin-6 (IL-6) is pleiotropic cytokine involved in many central nervous system disorders including stroke, and elevated serum IL-6 has been found in acute stroke patients. IL-6 is implicated in the inflammation, which contributes to both injury and repair process after cerebral ischemia. However, IL-6 is one of the neurotrophic cytokines sharing a common receptor subunit, gp130, with other neurotrophic cytokines, such as leukemia inhibitory factor (LIF) and ciliary neurotrophic factor. The expression of IL-6 is most prominently identified in neurons in the peri-ischemic regions, and LIF expression shows a similar pattern. The direct injection of these cytokines into the brain after ischemia can reduce ischemic brain injury. The cytokine receptors are localized on the neuron surface, suggesting that neurons are the cytokine target. The major IL-6 downstream signaling pathway is JAK-STAT, and Stat3 activation occurs mainly in neurons during postischemic reperfusion. Further investigation is necessary to clarify the exact role of Stat3 signaling in neuroprotection. Taken together, the information suggests that IL-6 plays a double role in cerebral ischemia, as an inflammatory mediator during the acute phase and as a neurotrophic mediator between the subacute and prolonged phases.

KW - Cerebral ischemia

KW - Interleukin-6

KW - JAK-STAT

KW - Leukemia inhibitory factor

KW - Neuron

KW - Stat3

UR - http://www.scopus.com/inward/record.url?scp=61349130664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61349130664&partnerID=8YFLogxK

U2 - 10.1038/jcbfm.2008.141

DO - 10.1038/jcbfm.2008.141

M3 - Article

C2 - 19018268

AN - SCOPUS:61349130664

VL - 29

SP - 464

EP - 479

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 3

ER -